Retractable Technologies (RVP) Stock Price, News & Analysis

Company Overview

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Key Stats

• Today's Range: $0.62 to $0.67
• 50-Day Range: $0.62 to $0.76
• 52-Week Range: $0.56 to $1.21
• Volume: 11,881 shs
• Average Volume: 54,025 shs
• Market Capitalization: $19.46 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Retractable Technologies Stock Analysis - MarketRank™

Retractable Technologies scored higher than 27% of companies evaluated by MarketBeat, and ranked 832nd out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Retractable Technologies.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Retractable Technologies is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Retractable Technologies is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Retractable Technologies has a P/B Ratio of 0.20. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.20% of the float of Retractable Technologies has been sold short.

Short Interest Ratio / Days to Cover

Retractable Technologies has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Retractable Technologies has recently decreased by 16.45%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Retractable Technologies does not currently pay a dividend.

Dividend Growth

Retractable Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.20% of the float of Retractable Technologies has been sold short.

Short Interest Ratio / Days to Cover

Retractable Technologies has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Retractable Technologies has recently decreased by 16.45%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 3 news articles for Retractable Technologies this week, compared to 0 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Retractable Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $181,915.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

57.10% of the stock of Retractable Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 7.58% of the stock of Retractable Technologies is held by institutions.

RVP Stock Analysis - Frequently Asked Questions

How have RVP shares performed this year?

Retractable Technologies' stock was trading at $0.6884 at the start of the year. Since then, RVP shares have decreased by 5.6% and is now trading at $0.65.
View the best growth stocks for 2025 here.

How were Retractable Technologies' earnings last quarter?

Retractable Technologies, Inc. (NYSE:RVP) announced its quarterly earnings results on Thursday, November, 15th. The company reported ($0.01) EPS for the quarter. The business earned $9.86 million during the quarter. Retractable Technologies had a negative net margin of 41.11% and a negative trailing twelve-month return on equity of 17.15%.

How do I buy shares of Retractable Technologies?

Shares of RVP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Retractable Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Retractable Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), CrowdStrike (CRWD), Salesforce (CRM).

Company Calendar

• Last Earnings: 11/15/2018
• Today: 7/01/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:RVP
• CIK: 946563
• Web: www.retractable.com
• Phone: (972) 294-1010
• Fax: 972-292-3600
• Employees: 240
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.77)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.01 million
• Net Margins: -41.11%
• Pretax Margin: -19.17%
• Return on Equity: -17.15%
• Return on Assets: -9.33%

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 8.57
• Quick Ratio: 5.92

Sales & Book Value

• Annual Sales: $33.75 million
• Price / Sales: 0.57
• Cash Flow: $0.01 per share
• Price / Cash Flow: 48.25
• Book Value: $3.31 per share
• Price / Book: 0.19

Miscellaneous

• Outstanding Shares: 29,940,000
• Free Float: 13,472,000
• Market Cap: $19.16 million
• Optionable: Optionable
• Beta: 1.39